Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 29, 2000
Liver transplantation for hereditary transthyretin amyloidosisO B Suhr, G Herlenius, S Friman, et al.
Transplantation Proceedings|November 14, 2006
MELD [corrected] score in patients accepted for liver transplantation 1994 to 2004A Flodén, M Castedal, S Friman, et al.
Transplantation Proceedings|March 17, 2007
Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004A Flodén, M Castedal, S Friman, et al.
Transplantation Proceedings|November 22, 2005
Nitric oxide-mediated effects on liver blood flowB I Gustafsson, M Wallin, D S Delbro, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
The liver protective effect of ischemic preconditioning may be mediated by adenosineB Nilsson, S Friman, M Wallin, et al.
Journal of the Autonomic Nervous System|August 27, 1996
Sympathetic and VIP-ergic control of calcium and bicarbonate transport in the feline gall bladder mucosa in vivoB Nilsson, D Delbro, S Friman, et al.
Acta Chirurgica Scandinavica|October 1, 1988
Relationship between gallbladder histopathology and ability to concentrate biliary lipids and bilirubin. A study on gallstone patients with functioning gallbladderG Rådberg, L Jivegård, S Friman, et al.
Nuclear Medicine Communications|March 1, 1996
Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteersM Ekman, M Fjälling, S Friman, et al.
Scandinavian Journal of Gastroenterology|October 1, 1995
Inflammation reduces mucosal secretion of hydrogen ions and impairs concentrating function and luminal acidification in feline gallbladderB Nilsson, S Friman, A Thune, et al.
Transplantation Proceedings|November 22, 2005
Preemptive therapy with pegylated interferon alpha-2b and ribavirin after liver transplantation for hepatitis C cirrhosisM Castedal, M Felldin, L Bäckman, et al.
Pageof 9